Light can enter bedrooms from outside sources and indoor devices. Sleep duration and quality are already tied to long-term heart outcomes in large observational research, and consensus guidance stresses adequate sleep for adults. A 2025 analysis adds a narrower question: when nights are measured as brighter by wrist sensors, are future cardiovascular diagnoses more common? The answer, in one very large cohort, is yes in a statistical sense, with important limits on what that means for cause.
Nighttime light on the wrist tied to heart and stroke outcomes
Researchers studied 88,905 UK Biobank participants (mean age 62.4 years; 56.9% female) who wore wrist-worn light sensors for about one week in everyday life, yielding roughly 13 million hours of light data. Nighttime brightness was grouped into percentiles; the analysis compared people in the brightest night band (91st to 100th percentiles) with those in the darkest nights (0 to 50th percentiles). Over roughly 9.5 years of follow-up through national health records, the authors’ model 3 hazard ratios for that contrast were 1.23 (95% CI, 1.10-1.38) for coronary artery disease, 1.42 (1.21-1.66) for myocardial infarction, 1.45 (1.24-1.69) for heart failure, 1.28 (1.15-1.43) for atrial fibrillation, and 1.28 (1.06-1.55) for stroke, in the primary adjusted models summarized in Table 2. Model 3 further adjusts for physical activity, smoking, alcohol, diet, and urbanicity after model 2 (education, employment, income, deprivation) and model 1 (age, sex, ethnicity, photoperiod). Hazard ratios under model 1 for the same percentile contrast are numerically higher because fewer covariates are included. The same report describes supplementary models that add other factors, such as sleep-related measures and polygenic scores, in separate analyses.
One lab night links room light to heart rate and insulin shifts
Cause cannot be read directly from cohort data. Experimental work in a sleep laboratory offers a complementary picture of short-term physiology. In 20 healthy young adults randomized to sleep one night under overhead room light near 100 lux versus two nights under dim light under 3 lux, the room-light condition caused a higher nighttime heart rate and lower heart-rate variability during sleep, a pattern read as higher sympathovagal balance (here, a shift toward more fight-or-flight nervous-system activity rather than rest-and-digest dominance). The next morning, the same condition was associated with a higher homeostatic model assessment of insulin resistance (HOMA-IR), a higher 30-minute insulin area under the curve from an oral glucose tolerance test, and a lower Matsuda insulin sensitivity index, compared with dim-light nights in this protocol. Melatonin levels did not clearly separate the arms in that study, and sleep architecture shifted somewhat (more stage N2, less slow-wave and REM sleep in the room-light condition). The authors frame sympathetic activation as a plausible pathway but stress a single acute exposure in 20 healthy young adults, so results may not generalize to older people, those with cardiometabolic disease, or dimmer, more typical bedroom lighting.
Circadian biology supplies general context: light is the main time cue for the brain’s central clock, which helps coordinate sleep, autonomic balance, and metabolism. Shift work that misaligns the clock with sleep opportunity is linked to higher long-term cardiovascular risk in population summaries. That background is consistent with broader circadian research, including shift-work studies, but it does not mean bedroom night light matches shift work in effect size or mechanism.
Why association here is not proof for your bedroom
The cohort study is strong on size and follow-up, but it remains observational. Residual confounding (for example, health status or bedroom environment factors not fully captured) can never be ruled out. Bright nights might partly mark people who are already at higher risk for unrelated reasons. Hazard ratios describe relative differences between exposure groups; they are not individualized probabilities.
The laboratory study shows biological responses after a single manipulated night, not clinical heart damage over years. Together, the two designs support a coherent pattern: brighter nights were linked to more cardiovascular disease in the cohort, and controlled light exposure can change heart-rate control and blood-sugar-related signals quickly in the lab, but they do not replace trials that would test whether darkening a bedroom prevents disease. Professional sleep guidance already treats sleep as a pillar of health; darkness is one lever alongside duration, regularity, and medical evaluation when symptoms persist.
Darker bedroom habits as a simple next step
The cohort discussion frames reducing night light as a complementary prevention idea consistent with the adjusted associations in the open-access report. For general sleep-environment advice, the CDC recommends keeping the bedroom cool, dark, and quiet and avoiding bright artificial light within a few hours of bedtime. Pair those habits with stable sleep timing, enough time in bed, and medical follow-up for chest pain, palpitations, sudden neurologic symptoms, or uncontrolled blood pressure. If you need light for safety or comfort, small changes still help, such as dimmer, warmer, or indirect sources placed away from the eyes during sleep.
Sources and related information
JAMA Network Open – Light exposure at night and cardiovascular disease incidence – 2025
This open cohort report supports the article’s claims about UK Biobank wrist light tracking, follow-up, model 1 through model 3 hazard ratios for night-light percentiles (including model 3 estimates used in the main results), supplementary models, and author disclosures plus the statement that funders had no role in design, conduct, analysis, manuscript approval, or submission.
PMC – Light exposure at night and cardiovascular disease incidence (full text) – 2025
This PMC full text of the same cohort analysis supports the article’s numeric model 3 hazard ratios and confidence intervals for coronary artery disease, myocardial infarction, heart failure, atrial fibrillation, and stroke when comparing the brightest and darkest night-light percentiles, together with Table 2 model definitions.
PNAS – Light exposure during sleep impairs cardiometabolic function – 2022
This parallel-group sleep-laboratory study in healthy young adults supports the article’s description of heart rate, heart-rate variability, sympathovagal balance, HOMA-IR, 30-minute insulin area under the curve, Matsuda index, melatonin comparisons, and sleep-stage shifts after one night of room-level versus dim overnight light.
CDC – About sleep and your heart health – 2024
This CDC heart-health sleep page supports the practical recommendation to keep the bedroom cool, dark, and quiet and to avoid bright artificial light near bedtime as part of sleep habits relevant to cardiovascular wellness messaging.
